|
A medication-supply-chain-for-Africa startup a day keeps the FOMO away.
|
Startup of the Year: Daily Dealflow
The Daily Dealflow newsletter delivers one startup a day, every work day to your inbox and is presented by Silicon Valley Bank.
Startup of the Year discovers and supports the most promising and innovative startups from around the world through #DailyDealflow, our Podcast & more.
|
Medsaf
Medsaf uses the latest medication supply chain management tools, and tracking and tracing technology to tackle the fake and substandard drug problem in Africa. Medsaf saves lives using technology!
|
|
Medsaf utilizes technology to make the process of buying and managing medication easy, and efficient. We provide value-added services to hospitals and pharmacies; safe medications, inventory management applications, financial services and tech enabled logistics partners. We track and trace medications from source to end user. We aggregate data from medications sales, scarce and in-demand medications, as well as locations and purchasing habits to help manufacturers and other health care stakeholders improve their offerings to Africa
|
What Problem Are They Solving?
In emerging markets like Nigeria, over 70% of medications are imported into the country. Due to poor infrastructure, uncontrolled borders, regulatory issues and parallel market dominance; fake and substandard medications are commonplace. Regular people cannot trust the medications they need.
Patients die from fake and substandard medications at alarming rates.
|
📍 Location
Lagos, Nigeria
|
|
⚙️ Product Stage
Alpha—Public
|
|
🏭 Industries
B2B, Hospital Services, Marketplaces, SaaS
|
|
|
🤑 Fundraising Status
Considering raising
|
|
💸 Total Funding Range To Date
$500k-$1.5MM
|
|
🙌 Founder Demographics
Female founder, Minority founder
|
|
|
Big Wins
- Partnered with the largest and most ethical pharmaceutical companies to distribute medications.
- Partnered with the largest health insurance company in Africa to offer our services to their hospitals.
- 400+ hospitals and pharmacies sign up to use the Medsaf service.
- Covered by Reuters and BBC for our work in the pharma industry in Africa.
- Created the first "Pay as you Go" financing option for drug procurement in Nigeria.
- Invited by the Nigerian government to pitch at competitions in South Korea, Paris, and across Nigeria.
- Won Most Impactful Company at the 2017 International Conference on Telecommunications in South Korea
- Won Best Female founded company at the Seedstars World Competition.
- Won Best Female founded company in Africa via Roland Berger and Women in Africa initiative.
|
Contact the Founder:
Vivian Nwakah
|
Startup of the Year Podcast raises the bar for startups around the world by providing further insight on the emerging companies featured in our Daily Dealflow newsletter and by highlighting newsworthy stories and global trends affecting the startup ecosystem. Subscribe today!
|
|
The Daily Dealflow is made possible thanks to the support of our amazing partners.
|
Silicon Valley Bank and its extensive team of early stage startup experts are supporters of startup communities everywhere. Click here to learn more. |
|
|
Do you travel for business? American Airlines® has a free, special offer for our friends – companies who enroll in their Business Extra program can earn up to 600 bonus Business Extra points. The program allows your travelers to earn their AAdvantage® miles while collectively earning Business Extra points for the business.
|
|
|
Startup of the Year is powered by Established, a consultancy focused on helping organizations with their innovation, startup, and communication strategies.
Created by the talent responsible for building the Tech.Co brand (acquired by an international publishing company), we're leveraging decades of experience to help our collaborators further (or create) their brand & accomplish their most important goals.
|
|
Established, LLC is not a broker-dealer and cannot provide assurances and makes no representations or warranties as to the timing or price terms for any purchase or sale of early-stage company equity. Nothing contained in this email constitutes investment, legal, tax or other advice. No information or statements contained in this email should be relied upon in making an investment or different decision. You should review all risks and consult all applicable professionals when making any investment decisions. Information and statements contained within this email and any attachments are solely for informational purposes and does not constitute an offer to sell or a solicitation to buy any securities.
|
|
|
|
|
